8,953 Matching Annotations
  1. Mar 2022
    1. or the endangerment of public health

      unless preventing people from freely discussing/sharing about what information/treatments they believe is effective/helpful for public health ... is actually more harmful to public health than allowing them to freely post.

  2. Feb 2022
    1. The Family Soup Company. (2022, February 19). A lesson in how misinformation becomes fact in too many minds. Thread: Meet @SaraCarterDC. Her bio says she’s an award winning correspondent who works with @FoxNews. Three hours ago, Sara tweeted that someone in the occupier demo died after police on horses pushed through. 1/ https://t.co/fpaYDctQVn [Tweet]. @mypoortiredsoul. https://twitter.com/mypoortiredsoul/status/1494912722156331008

    1. Marc Stegger. (2022, February 22). New preprint on #COVID19 is out: “Occurrence and significance of Omicron BA.1 infection followed by BA.2 reinfection”. Using the national surveillance system in Denmark, we show that reinfections with #SARSCoV2 VOC #Omicron BA.2 can occur after recent BA.1 infection #SSI_dk https://t.co/Cm0n8vga4P [Tweet]. @MarcStegger. https://twitter.com/MarcStegger/status/1496099303143653379

    1. Yen, H.-L., Sit, T. H., Brackman, C. J., Chuk, S. S., Cheng, S. M. S., Gu, H., Chang, L. D., Krishnan, P., Ng, D. Y., Liu, G. Y., Hui, M. M., Ho, S. Y., Tam, K. W., Law, P. Y., Su, W., Sia, S. F., Choy, K.-T., Cheuk, S. S., Lau, S. P., … Poon, L. L. (2022). Transmission of SARS-CoV-2 (Variant Delta) from Pet Hamsters to Humans and Onward Human Propagation of the Adapted Strain: A Case Study (SSRN Scholarly Paper ID 4017393). Social Science Research Network. https://doi.org/10.2139/ssrn.4017393

    1. Kok, K.-H., Wong, S.-C., Chan, W.-M., Lei, W., Chu, A. W.-H., Ip, J. D., Lee, L.-K., Wong, I. T.-F., Lo, H. W.-H., Cheng, V. C.-C., Ho, A. Y.-M., Lam, B. H.-S., Tse, H., Lung, D., Ng, K. H.-L., Au, A. K.-W., Siu, G. K.-H., & Yuen, K.-Y. (2022). Cocirculation of two SARS-CoV-2 variant strains within imported pet hamsters in Hong Kong. Emerging Microbes & Infections, 1–39. https://doi.org/10.1080/22221751.2022.2040922

    1. Stegger, M., Edslev, S. M., Sieber, R. N., Ingham, A. C., Ng, K. L., Tang, M.-H. E., Alexandersen, S., Fonager, J., Legarth, R., Utko, M., Wilkowski, B., Gunalan, V., Bennedbæk, M., Byberg-Grauholm, J., Møller, C. H., Christiansen, L. E., Svarrer, C. W., Ellegaard, K., Baig, S., … Rasmussen, M. (2022). Occurrence and significance of Omicron BA.1 infection followed by BA.2 reinfection (p. 2022.02.19.22271112). medRxiv. https://doi.org/10.1101/2022.02.19.22271112

    1. Tseng, H. F., Ackerson, B. K., Luo, Y., Sy, L. S., Talarico, C. A., Tian, Y., Bruxvoort, K. J., Tubert, J. E., Florea, A., Ku, J. H., Lee, G. S., Choi, S. K., Takhar, H. S., Aragones, M., & Qian, L. (2022). Effectiveness of mRNA-1273 against SARS-CoV-2 Omicron and Delta variants. Nature Medicine, 1–1. https://doi.org/10.1038/s41591-022-01753-y

    1. Cornelius Roemer. (2022, February 12). Fantastic work by @UKHSA comparing serial intervals of BA.1, BA.2 and Delta as published in the most recent technical briefing. BA.2 seems to have even shorter serial interval than BA.1 This could help explain different relative growth rates of BA.2 vs BA.1 in different countries https://t.co/Gch94Ew8CX [Tweet]. @CorneliusRoemer. https://twitter.com/CorneliusRoemer/status/1492434232664375304

    1. Altarawneh, H. N., Chemaitelly, H., Hasan, M. R., Ayoub, H. H., Qassim, S., AlMukdad, S., Coyle, P., Yassine, H. M., Al-Khatib, H. A., Benslimane, F. M., Al-Kanaani, Z., Al-Kuwari, E., Jeremijenko, A., Kaleeckal, A. H., Latif, A. N., Shaik, R. M., Abdul-Rahim, H. F., Nasrallah, G. K., Al-Kuwari, M. G., … Abu-Raddad, L. J. (2022). Protection against the Omicron Variant from Previous SARS-CoV-2 Infection. New England Journal of Medicine, 0(0), null. https://doi.org/10.1056/NEJMc2200133

    1. Lyngse, F. P., Mortensen, L. H., Denwood, M. J., Christiansen, L. E., Møller, C. H., Skov, R. L., Spiess, K., Fomsgaard, A., Lassaunière, M. M., Rasmussen, M., Stegger, M., Nielsen, C., Sieber, R. N., Cohen, A. S., Møller, F. T., Overvad, M., Mølbak, K., Krause, T. G., & Kirkeby, C. T. (2021). SARS-CoV-2 Omicron VOC Transmission in Danish Households (p. 2021.12.27.21268278). medRxiv. https://doi.org/10.1101/2021.12.27.21268278

    1. Shabari B., a Bengaluru resident, found 2020 challenging. Her daughter, now nine, did not take to online classes well. “She developed anxiety and this manifested in behavioural issues — she began to act out and would be rude to her teachers,” says the 44-year-old. The child missed her friends and her normal school day. Shabari’s younger child, now seven, was affected differently; the long months without seeing a single other person or going outside, affected his relationships with other people. “He used to be very vocal, but now he finds social situations very anxiety provoking,” says Shabari.

      Sisters face-off post-covid schooling behavioral issues

    1. Alastair Grant. (2022, February 16). Samples likely to be BA.2 (SGT positive in TaqPath data) now make up 34% of COVID cases in England. The proportion has roughly doubled in a week. That represents a growth in absolute numbers of BA.2, even if overall infections are falling at the same rate as reported cases https://t.co/LNr5baChby [Tweet]. @AlastairGrant4. https://twitter.com/AlastairGrant4/status/1493880986660225024

    1. Yamasoba, D., Kimura, I., Nasser, H., Morioka, Y., Nao, N., Ito, J., Uriu, K., Tsuda, M., Zahradnik, J., Shirakawa, K., Suzuki, R., Kishimoto, M., Kosugi, Y., Kobiyama, K., Hara, T., Toyoda, M., Tanaka, Y. L., Butlertanaka, E. P., Shimizu, R., … Sato, K. (2022). Virological characteristics of SARS-CoV-2 BA.2 variant (p. 2022.02.14.480335). bioRxiv. https://doi.org/10.1101/2022.02.14.480335

    1. Ali Ellebedy. (2021, December 30). We need those who are adept at #SciComm to explain that “Omicron” is sufficiently different from the original strain that was used to make the vaccine. Therefore, the definition of “fully vaccinated” will have to be updated, but that does not mean that the vaccines have failed. [Tweet]. @TheBcellArtist. https://twitter.com/TheBcellArtist/status/1476649138691444740

    1. Deepti Gurdasani. (2022, January 10). Lots of people dismissing links between COVID-19 and all-cause diabetes. An association that’s been shown in multiple studies- whether this increase is due to more diabetes or SARS2 precipitating diabetic keto-acidosis allowing these to be diagnosed is not known. A brief look👇 [Tweet]. @dgurdasani1. https://twitter.com/dgurdasani1/status/1480546865812840450

    1. Prof Claire J. Horwell 😷. (2021, December 2). With UK regs changing to mandatory #masks, here’s a short 🧵to answer the question: Can you wear a disposable #facemask more than once? The answer is YES. Many manufacturers state that masks should be disposed of after 8 hours but this is not true. Read on to find out why ... 1/ https://t.co/f9jXCKq3LT [Tweet]. @claire_horwell. https://twitter.com/claire_horwell/status/1466400270137630727

    1. Eric Feigl-Ding. (2022, January 17). Pandemic leadership matters. #COVID19 mortality per capita by state. 📍Public health is policy, policy is politics. 📍Human behavior is often driven by misinformation. 📍Misinformation is often driven by politics. 📍Politics can be changed by voting—Unless voters can’t. Https://t.co/pFkndQZrfr [Tweet]. @DrEricDing. https://twitter.com/DrEricDing/status/1483181226815012867

    1. APPG on Coronavirus. (2022, January 18). 🗣Dr.Claire Steves continued: “Looking in the national core studies, from cohort studies across the UK we’ve looked at 10 different longitudinal studies. Our best estimates are that about 5% of middle aged people are experiencing long term.. 27/ #APPGCoronavirus #LongCovid [Tweet]. @AppgCoronavirus. https://twitter.com/AppgCoronavirus/status/1483453895061999618

    1. Adam Kucharski. (2022, January 18). Below analysis was two years ago (https://bbc.co.uk/news/health-51148303). As well as providing an early warning about the COVID threat, it’s a good illustration of what is often an under-appreciated point: If we want to make sense of epidemic data and dynamics in real-time, we need models… 1/ https://t.co/ZdpzOq3Bzp [Tweet]. @AdamJKucharski. https://twitter.com/AdamJKucharski/status/1483368504392880128

    1. F. Perry Wilson, MD MSCE. (2022, February 4). If you, like me, are “skipping ahead” during the ACIP meeting re: Moderna vaccine—This slide really drives home the benefit / risk paradigm among the group at highest risk of myocarditis (men 18-35). 2 million shots = 1903 avoided hospitalizations, and 68 myocarditis cases. Https://t.co/3nzWXGXyD1 [Tweet]. @fperrywilson. https://twitter.com/fperrywilson/status/1489649379979972609

    1. Nick Mark MD. (2022, January 21). This FLCCC COVID protocol gets nuttier with each version. Now hydroxychloroquine is “preferred for omicron”? What?!🤯 Stuff that actually works (monoclonals & fluvoxamine) are 2nd line And steroids, which increased mortality in people NOT on O2 in RECOVERY, are recommended?😱 https://t.co/XXfn1eMTJt [Tweet]. @nickmmark. https://twitter.com/nickmmark/status/1484382662517137410

    1. Agarwal, A., Rochwerg, B., Lamontagne, F., Siemieniuk, R. A., Agoritsas, T., Askie, L., Lytvyn, L., Leo, Y.-S., Macdonald, H., Zeng, L., Amin, W., Barragan, F. A., Bausch, F. J., Burhan, E., Calfee, C. S., Cecconi, M., Chanda, D., Dat, V. Q., Sutter, A. D., … Vandvik, P. O. (2020). A living WHO guideline on drugs for covid-19. BMJ, 370, m3379. https://doi.org/10.1136/bmj.m3379

    1. Su, Y., Yuan, D., Chen, D. G., Ng, R. H., Wang, K., Choi, J., Li, S., Hong, S., Zhang, R., Xie, J., Kornilov, S. A., Scherler, K., Pavlovitch-Bedzyk, A. J., Dong, S., Lausted, C., Lee, I., Fallen, S., Dai, C. L., Baloni, P., … Heath, J. R. (2022). Multiple Early Factors Anticipate Post-Acute COVID-19 Sequelae. Cell, 0(0). https://doi.org/10.1016/j.cell.2022.01.014

    1. Heesakkers, H., van der Hoeven, J. G., Corsten, S., Janssen, I., Ewalds, E., Simons, K. S., Westerhof, B., Rettig, T. C. D., Jacobs, C., van Santen, S., Slooter, A. J. C., van der Woude, M. C. E., van den Boogaard, M., & Zegers, M. (2022). Clinical Outcomes Among Patients With 1-Year Survival Following Intensive Care Unit Treatment for COVID-19. JAMA, 327(6), 559–565. https://doi.org/10.1001/jama.2022.0040

    1. Afkhami, S., D’Agostino, M. R., Zhang, A., Stacey, H. D., Marzok, A., Kang, A., Singh, R., Bavananthasivam, J., Ye, G., Luo, X., Wang, F., Ang, J. C., Zganiacz, A., Sankar, U., Kazhdan, N., Koenig, J. F. E., Phelps, A., Gameiro, S. F., Tang, S., … Xing, Z. (2022). Respiratory mucosal delivery of next-generation COVID-19 vaccine provides robust protection against both ancestral and variant strains of SARS-CoV-2. Cell, S0092867422001453. https://doi.org/10.1016/j.cell.2022.02.005

    1. Krutika Kuppalli, MD FIDSA. (2022, January 14). If you had #COVID19 once you can get it again (and again). Risk of reinfection in England with #Omicron was ~5.4 fold higher compared to #Delta The relative risk were 6.36 & 5.02 for unvaxxd & vaxxd cases—Implies protection against reinfection by Omicron may be as low as 19% [Tweet]. @KrutikaKuppalli. https://twitter.com/KrutikaKuppalli/status/1482074117742288898

    1. Tyler Black, MD. (2022, January 4). /1 =-=-=-=-=-=-=- Thread: Mortality in 2020 and myths =-=-=-=-=-=-=- 2020, unsurprisingly, came with excess death. There was an 18% increase in overall mortality, year on year. But let’s dive in a little bit deeper. The @CDCgov has updated WONDER, its mortality database. Https://t.co/DbbvvbTAZQ [Tweet]. @tylerblack32. https://twitter.com/tylerblack32/status/1478501508132048901

    1. Adele Groyer. (2022, January 8). Friday report is now out. Https://covidactuaries.org/2022/01/07/the-friday-report-issue-58/ I am struck that perception of a “mild” Covid situation is relative. In SA natural deaths were >30% higher than predicted in Dec. The last time weekly death rates in E&W were more than 30% above 2015-19 levels was in Jan 2021. Https://t.co/S9fkn2WFVk [Tweet]. @AdeleGroyer. https://twitter.com/AdeleGroyer/status/1479760460589191170

    1. Trisha Greenhalgh. (2022, January 8). Apart from (e.g.): 1. Severe disease in clinically vulnerable (they are people too); 2. Long covid in many; 3. Strokes / heart attacks / kidney failure from micro-clots; 4. New-onset diabetes and MIS-C in children; 5. High potential for recombinant mutations. [Tweet]. @trishgreenhalgh. https://twitter.com/trishgreenhalgh/status/1479738523511136258

    1. In this paper, a design of an electronic nose was configured to detect the concentration of a COVID-19 breath simulation sample of alcohol, acetone, and carbon monoxide mixture. After preheating for 24 hours, the sample was carried into an internal bladder of the collection vessel for analysis and data was collected from three sensors to determine suitability of these sensors for the application of exhaled breath analysis. Test results show a detection range in parts-per-million within the sensor detection range of at least 10-300 ppm. The output response of an MQ-2 and an MQ-135 sensor to a diverse environment of target gasses show the MQ-2 taking a greater length of time to normalize baseline drift compared to an MQ-135 sensor due to cross interferences with other gasses. The COVID-19 breath simulation sample was established and validated based on preliminary data obtained from parallel COVID-19 breath studies based in Edinburgh and Dortmund.

      Simulasi breath COVID-19 dengan Enose MQ

    1. Ulrich Elling. (2022, January 12). While #Omicron BA.1 leads the race, the little sister BA.2 is catching up in numbers. They are rather different with likely functional implications. BA.2 might be more immune evasive in RBD, less in NTD. And due to reduced mutation load in NTD maybe different fusion properties? Https://t.co/kEACjzQDs3 [Tweet]. @EllingUlrich. https://twitter.com/EllingUlrich/status/1481214901997682692

    1. Dr Emma Hodcroft. (2022, January 28). Just to clarify some confusion about what “Omicron” is. “Omicron” has always applied to the whole family (BA.1-3—We’ve known about them all since late-Nov/early-Dec). But the prevalence of BA.1 meant that it got shorthanded as ’Omicron’—That’s causing some confusion now!🥴 https://t.co/M4FwzGbluo [Tweet]. @firefoxx66. https://twitter.com/firefoxx66/status/1486999566725656576

    1. Prof. Gavin Yamey MD MPH. (2022, January 21). His vax disinformation is at 34.55 in the video His full comments: “But people do not trust this vaccine. It’s not been through the normal trials, it’s a technology that’s not been proven as safe & effective, & now the data is coming in on the vaccine that’s showing that..” 1/3 [Tweet]. @GYamey. https://twitter.com/GYamey/status/1484668215825469445

    1. (((Howard Forman))). (2022, January 21). NYC update (GREAT news heading into weekend) Cases down 43% with positive rate 7.3% (Manhattan 6.2%). Lowest rate since December 15. Hospital census down 13% back to levels of January 2. All trends (except deaths) favorable. Thanks to everyone who has helped get us here. Https://t.co/MLmptWLxKv [Tweet]. @thehowie. https://twitter.com/thehowie/status/1484608013885480962

    1. BNO Newsroom. (2022, January 28). U.S. COVID update: Daily cases drop 13 days in a row, deaths still rising—New cases: 546,598—Average: 600,789 (-29,966)—States reporting: 46/50—In hospital: 143,574 (-2,881)—In ICU: 25,099 (-254)—New deaths: 3,061—Average: 2,525 (+88) Data: Https://newsnodes.com/us [Tweet]. @BNODesk. https://twitter.com/BNODesk/status/1486860664291446787